Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 15 studies | 66% ± 19% | |
glutamatergic neuron | 12 studies | 77% ± 21% | |
GABAergic neuron | 11 studies | 63% ± 20% | |
astrocyte | 7 studies | 38% ± 19% | |
interneuron | 6 studies | 54% ± 26% | |
neuron | 5 studies | 41% ± 18% | |
endothelial cell | 4 studies | 46% ± 18% | |
microglial cell | 4 studies | 37% ± 18% | |
GABAergic interneuron | 3 studies | 78% ± 1% | |
GABAergic amacrine cell | 3 studies | 29% ± 9% | |
ON-bipolar cell | 3 studies | 57% ± 28% | |
rod bipolar cell | 3 studies | 73% ± 30% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 17 studies | 44% ± 25% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 85% | 184.54 | 2245 / 2642 | 44% | 2.18 | 307 / 705 |
blood vessel | 18% | 6.67 | 234 / 1335 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 9% | 0.18 | 81 / 901 |
lung | 2% | 0.86 | 14 / 578 | 0% | 0.01 | 5 / 1155 |
liver | 0% | 0 | 0 / 226 | 2% | 0.04 | 9 / 406 |
skin | 0% | 0.06 | 1 / 1809 | 1% | 0.01 | 3 / 472 |
pancreas | 0% | 0 | 0 / 328 | 1% | 0.01 | 1 / 178 |
adrenal gland | 0% | 0 | 0 / 258 | 0% | 0.00 | 1 / 230 |
muscle | 0% | 0.06 | 2 / 803 | 0% | 0 | 0 / 0 |
breast | 0% | 0 | 0 / 459 | 0% | 0.00 | 2 / 1118 |
adipose | 0% | 0.05 | 2 / 1204 | 0% | 0 | 0 / 0 |
thymus | 0% | 0.04 | 1 / 653 | 0% | 0 | 0 / 605 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 0% | 0 | 0 / 504 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
esophagus | 0% | 0 | 0 / 1445 | 0% | 0 | 0 / 183 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
intestine | 0% | 0 | 0 / 966 | 0% | 0 | 0 / 527 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ovary | 0% | 0 | 0 / 180 | 0% | 0 | 0 / 430 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
prostate | 0% | 0 | 0 / 245 | 0% | 0 | 0 / 502 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
stomach | 0% | 0 | 0 / 359 | 0% | 0 | 0 / 286 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
uterus | 0% | 0 | 0 / 170 | 0% | 0 | 0 / 459 |
GO_0048170 | Biological process | positive regulation of long-term neuronal synaptic plasticity |
GO_0050850 | Biological process | positive regulation of calcium-mediated signaling |
GO_0099566 | Biological process | regulation of postsynaptic cytosolic calcium ion concentration |
GO_0002029 | Biological process | desensitization of G protein-coupled receptor signaling pathway |
GO_0007612 | Biological process | learning |
GO_0007611 | Biological process | learning or memory |
GO_0007206 | Biological process | phospholipase C-activating G protein-coupled glutamate receptor signaling pathway |
GO_0007196 | Biological process | adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway |
GO_0099553 | Biological process | trans-synaptic signaling by endocannabinoid, modulating synaptic transmission |
GO_0007216 | Biological process | G protein-coupled glutamate receptor signaling pathway |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0051966 | Biological process | regulation of synaptic transmission, glutamatergic |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0060078 | Biological process | regulation of postsynaptic membrane potential |
GO_0050890 | Biological process | cognition |
GO_0050808 | Biological process | synapse organization |
GO_1904646 | Biological process | cellular response to amyloid-beta |
GO_0007626 | Biological process | locomotory behavior |
GO_0007205 | Biological process | protein kinase C-activating G protein-coupled receptor signaling pathway |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0098839 | Cellular component | postsynaptic density membrane |
GO_0098685 | Cellular component | Schaffer collateral - CA1 synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0043197 | Cellular component | dendritic spine |
GO_0043198 | Cellular component | dendritic shaft |
GO_0030425 | Cellular component | dendrite |
GO_0097449 | Cellular component | astrocyte projection |
GO_0005737 | Cellular component | cytoplasm |
GO_0008066 | Molecular function | glutamate receptor activity |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0031687 | Molecular function | A2A adenosine receptor binding |
GO_0099583 | Molecular function | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration |
GO_0042802 | Molecular function | identical protein binding |
GO_1990782 | Molecular function | protein tyrosine kinase binding |
GO_0099530 | Molecular function | G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential |
GO_0030296 | Molecular function | protein tyrosine kinase activator activity |
GO_0001640 | Molecular function | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | GRM5 |
Protein name | Metabotropic glutamate receptor 5 variant H Metabotropic glutamate receptor 5 variant G Metabotropic glutamate receptor 5 variant F GRM5 variant 9 Glutamate metabotropic receptor 5 Metabotropic glutamate receptor 5 (mGluR5) |
Synonyms | MGLUR5 GPRC1E |
Description | FUNCTION: G-protein coupled receptor for glutamate. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling activates a phosphatidylinositol-calcium second messenger system and generates a calcium-activated chloride current. Plays an important role in the regulation of synaptic plasticity and the modulation of the neural network activity. . |
Accessions | G8XUU6 K9J9K9 A8MT20 ENST00000305432.9 [P41594-2] G8XUU8 P41594 ENST00000305447.5 [P41594-1] ENST00000393294.3 ENST00000455756.6 [P41594-2] G8XUU7 ENST00000449371.6 H7C223 |